42.8  0.51 (1.21%)		07-16 16:00
Open: 42.59 High: 44.36 Volume: 97,967		Pre. Close: 42.29 Low: 42.25 Market Cap: 354(M)

Short term
Mid term
Targets	6-month :	55.36	1-year :	64.66
Resists	First :	47.4	Second :	55.36
Pivot price	43.89
Supports	First :	40.11	Second :	35.61
MAs	MA(5) :	44.21	MA(20) :	42.51
	MA(100) :	31.27	MA(250) :	27.46
MACD	MACD :	1.9	Signal :	2.3
%K %D	K(14,3) :	52.8	D(3) :	65.8
RSI	RSI(14): 55.1
52-week	High :	47.4	Low :	17.72

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ELMD ] has closed above bottom band by 35.4%. Bollinger Bands are 24.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	44.42 - 44.67	44.67 - 44.9
Low:	41.61 - 41.93	41.93 - 42.22
Close:	42.34 - 42.8	42.8 - 43.22

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Fri, 10 Jul 2026
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX - The Globe and Mail

Mon, 06 Jul 2026
Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Thu, 02 Jul 2026
Electromed (ELMD) CFO forfeits shares to cover restricted stock taxes - Stock Titan

Mon, 08 Jun 2026
[144] Electromed, Inc. SEC Filing - Stock Titan

Mon, 01 Jun 2026
Electromed, Inc. (ELMD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Tue, 19 May 2026
Electromed, Inc. (ELMD)'s Technical Outlook is Bright After Key Golden Cross - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: AMEX
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.